TaxTMI 
TaxTMI 
TaxTMI 
FDI in Pharmaceuticals
X X X X Extracts X X X X
X X X X Extracts X X X X
....DI in Pharmaceuticals <br>News and Press Release<br>Dated:- 5-8-2013<br><BR>Indian pharmaceutical sector has witnessed increased foreign investment in the form of strategic collaborations, mergers and acquisitions as per available information from different sources. Foreign Direct Investment in the pharmaceutical sector was allowed upto 100% on the automatic route till November, 2011, when government reviewed the policy in view of the pattern of foreign investment. As a result of the review, Foreign Direct Investment in existing entities (brownfield) in the pharma sector was put on the government approval route for the necessary scrutiny. Further, in order to ensure availability of essential medicines and maintain a reasonable level of research and development expenditure, government prescribed appropriate conditionalities for approvals under the government approval route. The extant policy on Foreign Direct Investment (FDI) in the pharmaceutical sector is at Annexure-I. It is expected that Foreign Direct Investment should strengthen the domestic pharmaceutical sector by augmenting the availability of capital and technology for production, marketing, research & development. This s....
X X X X Extracts X X X X
X X X X Extracts X X X X
....hould in turn positively impact the availability of lifesaving drugs in the country through enhanced production as well as introduction of new drugs. Annexure-I ANNEXURE REFERRED TO IN REPLY TO LOK SABHA UNSTARRED QUESTION NO. 174 FOR ANSWER ON 5.8.2013. Sl. No. Sector/Activity % of FDI Cap/Equity Entry Route 6.2.18 Pharmaceuticals 6.2.18.1 Greenfield 100% Automatic 6.2.18.2 Brownfield 100% Government Note:Government may incorporate appropriate conditions for FDI in brownfield cases, at the time of granting approval. Major cases of such FDI are placed at annexure - II Click here to see Annexure The information was given by the Minister of Commerce & Industry, Shri Anand Sharma, in a written reply in the Lok Sabha. ============= Document 1 Annex-II ANNEXURE REFERRED TO IN REPLY TO PARTS (c) TO (e) OF LOK SABHA UNSTARRED QUESTION NO. 174 FOR ANSWER ON 5.8.2013. DETAILED BREAK-UP FOR FDI APPROVED DURING APRIL 2010 TO MAY 2013 Sector: DRUGS AND PHARMACEUTICALS SI. Registration Indian Company Name No No and Address and Date Foreign Collaborator Name and Address Foreign Equity %age of Foreign Equity in Rs million in US$million ....
X X X X Extracts X X X X
X X X X Extracts X X X X
.... 1 67 STELLENCE 07 April 2012 PHARMSCIENCE PVT LTD, BANGALORE #456, ROAD#3, INDUSTRIAL AREA, JIGANI, Country CFR INTL. SPA, CHILE. Chile 1,000.00 18.86 50.00 BANGALORE-560105 KARNATAKA. Location: BANGALORE (URBAN)(KARNATAKA) Appr No(Date): 83(31 October 2012) Item of Manufacture: MANUFACTURE AND SALE OF ACTIVE PHARMACEUTICAL INGREDIENTS & ADVANCED INTERMEDIATES. Total Financial Cases : 1 Total Foreign Equity in Rs million : 1,000.00 US$ million : 18.86 Country France 2 252 31 December (INDIA) LIMITED 2012 MUMBAI SANOFI SYNTHELABO M/S SANOFI S.A. FRANCE C/O KUNAL THAKORE, 3RD FLOOR KALAPATARU HERITAGE 127 MG ROAD MUMBAI 1,800.00 32.72 100.00 Location: GREATER MUMBAI (MUMBAI)(MAHARASHTRA) Appr No(Date): 22(31 May 2013) Item of Manufacture: ENGAGED IN THE BUSINESS OF MANUFACTURING MARKETINGSELLING AND DISTRIBUTING PHARMACEUTICALS. Total Financial Cases : 1 Total Foreign Equity in Rs million : 1,800.00 : US$ million : 32.72 Country Germany 3 214 AET LABORATORIES ALFRED E 05 November PVT LTD. C/O BATTULA 2012 TIEFENBACHER SRINIVASA (GMBH & CO. KG) GERMANY GADDAPOTHARAM RAO SURVEY NO.- 42 KAZIPALLY INDUSTRIAL AREA MEDAK DIST....
X X X X Extracts X X X X
X X X X Extracts X X X X
....RICT 502319 64.13 1.18 100.00 Location MEDAK(ANDHRA PRADESH) Appr No(Date): 15(30 April 2013) Item of Manufacture: DEVELOPING PHARMACEUTICAL FORMULATIONS PREPARATION OF PHARMACEUTICAL DOSSIERS AND MANUFACTURING OF FINISHED DOSAGE FORMS Total Financial Cases : 1 Total Foreign Equity in Rs million : 64.13 US$ million : 1.18 Country Hungary ORDAIN HEALTH CARE CHEMO ESPANA S. GLOBAL PRIVATE LTD L. SPAIN 4 |14 25 January 2012 CHENNAI C/O KUNDRA & BANSAL, 588.50 11.10 60.00 B-231, GREATER KAILASH-1, NEW DELHI-110048 Location: CHENNAI (TAMIL NADU) Appr No(Date): 79(31 October 2012) Item of Manufacture: MANUFACTURING, RESEARCH & DEVELOPMENT FOR TECHNOL-OGY ADVANCEMENT AND MARKETING OF PHARMACEUTICAL FINISHED DOSAGE FORMULATIONS SI. Registration Indian Company Name No No and Address and Date Foreign Collaborator Name and Address Total Financial Cases : Foreign Equity %age of Foreign Equity in Rs million in US$million 1 Total Foreign Equity in Rs million : 588.50 US$ million : 11.10 Country Japan 5 21 CLARIS OTSUKA LTD., YTSUKA 10,500.00 193.10 80.00 17 January 2013 AHMEDABAD C/O BMR ADVISORS, PHARMACEUTICAL FACTORY INC. 22ND F....
X X X X Extracts X X X X
X X X X Extracts X X X X
....LOOR, BUILDING NO.5 TOWER A. DLF CYBER CITY DLF PHASE III GURGAON Location AHMEDABAD(GUJARAT) Appr No(Date): 2(30 April 2013) 6 41 ARCH PHARMALABS 23 February 2012 LTD MUMBAI, 541-A, MITSUI & CO. LTD JAPAN ARCH HOUSE MAROL MAROSHI ROAD MAROL, ANDHERI (EAST), MUMBAI-400059 Item of Manufacture: DEVELOPMENT MANUFACTURING AND MARKETING OF PHARMC EUTICAL PRODUCTS 0.00 0.00 46.48 7 211 31 October 2012 Location: GREATER MUMBAI (MUMBAI)(MAHARASHTRA) Appr No(Date): 81(31 October 2012) SAURAV CHEMICALS LTD. PUNJAB C/O MR. ADITYA BHAT. AZB & PARTNERS 67/4, 4TH CROSS, LAVELLE ROAD, BANGALORE-560001 MITSUBISHI CORPORATION, JAPAN Location: ROPAR(PUNJAB) Appr No(Date): 119(31 January 2013) Item of Manufacture: MANUFACTURE AND SALE OF ACTIVE PHARMACEUTICAL INGREDIENTS AND CONTRACT RESEARCH AND MANUFACTURING SERVICES 148.50 2.73 10.00 Item of Manufacture: MANUFATURING OF PHARMACEUTICALS INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS Total Financial Cases : 3 Total Foreign Equity in Rs million 10,648.50 : US$ million 195.83 Country Mauritius MYLAN LABORATORIES M/S MP LIMITED HYDERABAD 8 22 22 January 2013 C/O COOP- 9 85 |PRICE....
X X X X Extracts X X X X
X X X X Extracts X X X X
....WATERHOUSE ERS PRIVATE LTD. BUILDING NO. 10 TOWER C 17TH FLOOR DLF CYBER CITY GURGAON 122002 LABORATORIES (MAURITIUS) LIMITED MAURITIUS Location: HYDERABAD (TWIN CITIES)(ANDHRA PRADESH) Appr No(Date): 25(31 May 2013) VYOME BIOSCIENCES 20 April 2012 PRIVATE LIMITED C/O K LAW A-457, DEFENCE COLONY NEW DELHI-110024 INDO US VENTURE PARTNER II, LLC MAURITIUS, DR. ERMANNO GHERARDI AND DR. JEFFERY 0.00 0.00 97.82 Item of Manufacture: MANUFACTURING OF ACTIVE PHARMACEUTICALS INGREDIENT-S AND SOLID ORAL DOSAGE FORMULATIONS 125.00 2.36 26.96 SI. Registration Indian Company Name No No and Address and Date Foreign Collaborator Name and Address 10 119 05 June 2012 11 121 06 June 2012 12 139 29 June 2012 KARP Foreign Equity in Rs million in US$million %age of Foreign Equity Location: DELHI(DELHI) Appr No(Date): 85(31 October 2012) Item of Manufacture: RESEARCH AND DEVELOPMENT IN PHARMACEUTICALS, BIO- TECHNOLOGY, NANOTECHNOLOGY AND LIFE SCIENCES SHASUN PHARMACEUTICALS LTD., "BATRA CENTRE", CADUCEUS ASIA MAURITIUS LTD., MAURITIUS. 13.16 0.24 11.93 NO.28, SARDAR PATEL ROAD, POST BOX 2630, GUINDY, CHENNAI-600032. Location: ....
X X X X Extracts X X X X
X X X X Extracts X X X X
....CHENNAI(TAMIL NADU) Appr No(Date): 61(31 July 2012) ZIM LABORATORIES LTD NAGPUR J. SAGAR ASSOCIATES, VAKILS HOUSE 18 SPROTT ROAD, BALLARD ESTATE MUMBAI-400001 AA DEVELOPMENT CAPITAL INDIA FUND I, LLC MAURITIUS & DR. IGUE- LMOUNAIM, ALGERIA Location: NAGPUR(MAHARASHTRA) Appr No(Date): 86(31 October 2012) Item of Manufacture: MANUFACTURE OF PHARMACEUTICAL INGREDIENTS, FORMULATIONS, BIO-TECH AND NANO TECHNOLOGY PRODUCTS. 504.49 9.51 Item of Manufacture: BUSINESS OF 24.61 MANUFACTURING DISTRIBUTION & MARKETINGOF FORMULATION IN ALLOPATHIC & HERBAL CATEGORIES ENCOMPASSING ALMOST EVERY DOSAGE FROM SUCH AS-NDDS(I.E. PELLETS, TASTE MASKED GRANULES, DIRECTLY CO- PRESSIBLE GRANULES AND MOUTH DISSOLVING FILMS) ADVANCED ENZYMES TEECHNOLOGIES LTD, MAGNETICA, 5TH SUN FLOOR, "A" WING NEAR LIC SERVICE KOTAK INDIA VENTURE (OFFSHORE) FUND MAURITIUS 97.61 1.78 57.96 ROAD LOUISWADI THANE MAHARASHTRA Location THANE (MAHARASHTRA) Appr No(Date): 98(30 November 2012) Item of Manufacture: ENGAGED IN THE MANUFACTURING OF ENZYMES AND ENZYME BASED SOLUTIONS AND PROBIOTIES AND DIDICAT- ED TO MARKETING ECO-SAFE SOLUTION TO WIDE VARIETY OF INDUSTRIES LIKE HU....
X X X X Extracts X X X X
X X X X Extracts X X X X
....MAN NUTRITION, ANIMAL NUTRITI-ON, BAKING, FRUIT PROCESSING BIOMASS PROCESSING 13 196 SAI LIFE SCIENCES SEQUOIA CAPITAL 10 October 2012 LTD., HYDERABAD, C/O INDIA THEMIS ASSOCIATES, 715-716, INVESTMENTS III, MAURITIUS. OXFORD TOWERS, HAL AIRPORT ROAD, 0.00 0.00 59.72 BANGALORE-560008. Location: HYDERABAD (TWIN CITIES)(ANDHRA PRADESH) Appr No(Date): 109(31 December 2012) Item of Manufacture: BUSINESS OF INTEGRATED DRUG DISCOVERY & DEVELOPME-NT SERVICES, KNOW HOW, MFG PROCESS FOR CHEMICALS, DRUGS & PHARMACEUTICALS. 14 203 MYLAN LABORATORIES MP LABORATORIES 0.00 0.00 97.82 SI. Registration Indian Company Name No No and Date and Address Foreign Collaborator Name and Address Foreign Equity %age of Foreign Equity in Rs million in US$million 19 October 2012 LTD, HYDERABAD, C/O PRICEWATER (MAURITIUS) LTD., MAURITIUS. HOUSE COOPERS PVT LTD., BUILDING NO. 10, TOWER C, 17TH FLOOR, DLF CYBER CITY, GURGAON-122002. Location: HYDERABAD (TWIN CITIES)(ANDHRA PRADESH) Appr No(Date): 111(31 December 2012) Item of Manufacture: MFG OF ACTIVE PHARMACEUTICAL INGREDIENTS & SOLID ORAL DOSAGE FORMULATION. 15 227 22 November 2012 SYNGENE INTER....
X X X X Extracts X X X X
X X X X Extracts X X X X
....NATIONAL LTD BANGALORE C/O BMR & ASSOCIATES LLP. 22ND FLOOR. BUILDING NO.- 5 TOWER A DLF CYBER CITY DLF PHASE III GURGAON 122002 GE EQUITY INTERNATIONAL MAURITIUS 1,250.00 23.01 8.00 Location: BANGALORE (URBAN)(KARNATAKA) Appr No(Date): 122(31 January 2013) Item of Manufacture: CONTRACT RESEARCH AND DEVELOPMENT SERVICES TO THIRD PARTIES ENGAGED IN THE PHARMACEUTICAL NUTRITION AND MATERIAL SCIENCE INDUSTRIES UNDER FEE FOR SERVICE COMMERCIAL ARRANGEMENTS. Total Financial Cases : 8 Total Foreign Equity in Rs million : 1,990.26 : US$ million : 36.90 Country NRI (As Individual Investor) NRIS. 100.00 1.78 4.67 16 13 SUN PHARMA 25 January 2012 ADVANCED RESEARCH CO. LTD, 17-B, MAHAL INDUSTRIAL ESTATE, MAHAKALI CAES ROAD, ANDHERI (EAST), MUMBAI-400093. Location State Not Indicated (State Not Indicated) Appr No(Date): 37(30 June 2012) ELIGIBLE FOREIGN INVESTORS. Item of Manufacture: BUSINESS OF DEVELOPING NEW PROPRIETARY DRUGS VIZ., NEW CHEMICAL ENTITIES & NOVEL DRUG DELIVERY SYSTEMS. 5,603.02 100.00 27.83 17 30 PLETHICO 08 February 2012 PHARMACEUTICALS LTD, C/O CRAWFORD BAYLEY & CO., STATE BANK BUILDI, 18 216 14 December 2011....
X X X X Extracts X X X X
X X X X Extracts X X X X
.... N.G.N. VAIDYA MARG, MUMBAI-400023. Location State Not Indicated (State Not Indicated) Appr No(Date): 46(30 June 2012) ANKUR DRUGS & PHARMA LTD, C/O INNOVISION CORPORATE CONSULTANTS PVT LTD, BLOCK NO.2, SAMATA SADAN, NON RESIDENT QUALIFIED INSTITUTIONAL BUYERS. Item of Manufacture: BUSINESS OF MANUFACTURING, MARKETING & DISTRIBUTI-NG NUTRACEUTICAL, HERBAL & ALLOPATHIC PRODUCTS. 400.00 7.14 34.08 SI. Registration Indian Company Name No No and Address and Date Foreign Foreign Equity Collaborator Name and Address in Rs million in US$million %age of Foreign Equity 19 223 19 November 2012 S.H.PARALKAR MARG, SHIVAJI PARK, MUMBAI-400028. Location State Not Indicated (State Not Indicated) Appr No(Date): 45(30 June 2012) AANJANEYA LIFECARE LTD. MUMBAI C/O YOGESH PATEL, AANJANEYA HOUSE, PLOT NO. 34 POSTAL COLONY CHEMBUR MUMBAI-40001, MAHARASHTRA INDIA ELIGIBLE FOREIGN INVESTORS (NRI) Item of Manufacture: BUSINESS OF MANUFACTURING OF PHARMACEUTICAL FORMULATIONS. 4,050.00 74.56 28.00 20 76 Location: GREATER MUMBAI (MUMBAI) (MAHARASHTRA) Appr No(Date): 120(31 January 2013) Item of Manufacture: ENGAGED IN THE BUSINESS OF CONTRACT R....
X X X X Extracts X X X X
X X X X Extracts X X X X
....ESEARCH AND MANUFACTURING SERVICES AND MANUFACTURING OF ACTIVEPHARMACEUTICAL INGREDIENTS AND FINISHED DOSAGE FORMS. Total Financial Cases : 4 Total Foreign Equity in Rs million PFIZER LTD. MUMBAI, 17 April 2012 C/O ERNST & YOUNG PVT LTD GOLF VIEW CORPORATE TOWER B, SECTOR-42, SECTOR ROAD GURGAON-122002 Country Netherlands PAH INDIA HOLDING I B V, NETHERLANDS, AND PAH INDIA HOLDCO LLC USA 10,153.02 US$ million 183.49 8,000.00 150.88 100.00 Location: GREATER MUMBAI(MUMBAI)(MAHARASHTRA) Appr No(Date): 84(31 October 2012) 21 179 DMV-FONTERRA 26 August EXCIPIENTS B.V., C/O 2011 |PRICEWATERHOUSE- COOPERS PVT LTD.,BUILDING NO. 10, 17TH FLOOR, DMV-FONTERRA EXCIPIENTS BV, NETHERLANDS. Item of Manufacture engaged in pharmaceutical sector 393.60 7.99 TOWER-C, DLF CYBER CITY, GURHAON-122002. Location State Not Indicated (State Not Indicated) Appr No(Date): 94(31 October 2011) PERRIGO API INDIA Item of Manufacture: BUSINESS OF MANUFACTURING & SALE OF PHARMACEUTICALEXCIPIENTS. 550.00 10.23 22 198 14 October 2012 PVT LTD, PLOT NO. N 39/N 39-1, ADDITIONAL MIDC, ANAND NAGAR, AMBERNATH (E)- 421 506, DISTT. THANE, MAHARASHTRA. Locatio....
X X X X Extracts X X X X
X X X X Extracts X X X X
....n: GREATER PERRIGO ISRAEL HOLDINGS II BV, NETHERLANDS. MUMBAI (MUMBAI) (MAHARASHTRA) Appr No(Date): 131(28 February 2013) Item of Manufacture: MANUFACTURE OF PHARMACEUTICAL INGREDIENTS. Total Financial Cases : 3 Total Foreign Equity in Rs million 8,943.60 US$ million 169.09 23 258 Country Phillipines BALAJADIA NO.73, SCOUT 23 December HEALTHCARE PVT LTD, ZENAIDA DIZON, 2011 SOFTGEL NO. 15, GOPALKRISHNAN ROAD, T. NAGAR, FERNANDEZ, BARANGAY LAGING HANDA, SACRED 0.00 0.00 100.00 89.30 32.97 SI. Registration Indian Company Name No No and Address and Date Foreign Collaborator Name and Address 24 11 08 January 2013 CHENNAI-600017. Foreign Equity in Rs million in US$million GEART QUEZON CITY, %age of Foreign Equity PHILIPPINES-1103. Location: KANCHEEPURAM (TAMIL NADU) Appr No(Date): 17(31 March 2012) Total Financial Cases : OXFORD LFESCIENCES PVT. LTD. C/O SHANKER AND KAPA- NI CHARTERED ACCOUNTANTS NTC HOUSE, 2ND FLOOR, 15 MORARJEE MARG. BALLARD ESTATE MUMBAI-400038 Item of Manufacture: BUSINESS OF CONTRACT MANUFACTURING FOR DOMESTIC & EXPORT OF SOFT GELATINE CAPSULES. 1 Total Foreign Equity in Rs million 0.00 US$ million 0.00....
X X X X Extracts X X X X
X X X X Extracts X X X X
.... Country Russia MR. ANDERY MEDUNITSYN RUSSIAN NATIONAL 1.85 0.03 47.00 Location: GREATER MUMBAI(MUMBAI)(MAHARASHTRA) Appr No(Date): 23(31 May 2013) Item of Manufacture: ENGAGED IN THE BUSINESS OF MANUFACTURING AND EXPORTING OF PHARMACEUTICALS AND HEALTHCARE PRODUCTS Total Financial Cases : 1 Total Foreign Equity in Rs million 1.85 US$ million: 0.03 Country Singapore 25 16 SPHAERA PHARMA PVT SPHAERA PHARMA 0.30 0.01 99.99 31 January 2012 LTD, REGD OFFICE: E- 375, PTE LTD., SINGAPORE. FIRST FLOOR, 26 64 GREATER KAILASH-II, NEW DELHI-110048. Location State Not Indicated (State Not Indicated) Appr No(Date): 18(31 March 2012) B BRAUN SINGAPORE 04 April 2012 PTE LTD, SINGAPORE, 27 131 22 June 2012 C/O BALAJI V, 33 SOUTH BEACH AVENUE, II CROSS, MRC NAGAR, CHENNAI-600028. Location: DELHI(DELHI) B BRAUN SINGAPORE PTE LTD., SINGAPORE Appr No(Date): 82(31 October 2012) FRESENIUS KABI (SINGAPORE) PTE. LTD, SINGAPORE C/O AMARDAS MANGALDAS & SURESH A SHROFF & CO. FRESENIUS KABI (SINGAPORE) PTE LTD., SINGAPORE. Item of Manufacture: BUSINESS OF DRUG DISCOVERY AND DEVELOPMENT. 0.00 0.00 75.00 Item of Manufacture: BUSINESS OF LIFE SAV....
X X X X Extracts X X X X
X X X X Extracts X X X X
....ING INTRAVENOUS FLUIDS AND OPHTHALMIC PRODUCTS. 0.00 0.00 99.81 AMARCHAND TOWER, 216, 28 154 OKHLA INDUSTRIAL ESTATE, PHASE III, NEW DELHI- 20. Location DELHI(DELHI) Appr No(Date): 69(30 September 2012) CALYX CHEMICALS 23 July 2012 AND PHARMACEUTICALS MARBLE ARCH GROUP LTD, SINGAPORE Item of Manufacture: BUSINESS OF RESEARCH, DEVELOPMENT, PRODUCDTION, MANUFACTURING, SALE, MARKETING, PROMOTION & DISTRIBUTION OF FORMULATION USED IN THE TREATMENT OF ONOCOLOGY PATIENTS. 30.69 0.56 10.20 SI. Registration Indian Company Name No No and Address and Date Foreign Collaborator Name and Address LTD MUMBAI UNIT NO.-2, MARWAH COMPLEX MARWAH ESTATE SAKI VIHAR ROAD, ANDHERI (EAST) MUMBAI-400072 Location: GREATER MUMBAI (MUMBAI) (MAHARASHTRA) Appr No(Date): 96(30 November 2012) 29 188 20 HOSPIRA INC. USA, C/O KHAITAN & CO., HOSPIRA PTE LTD., SINGAPORE. September 2012 1105, ASHOKA ESTATE, Foreign Equity %age of Foreign Equity in Rs million in US$million Item of Manufacture: ENGAGED IN THE MANUFACTURING OF ACTIVE PHARMACEUT-ICALS INGREDIENTS AND INTERMEDIATES IN INDIA AND MANUFACTURE OF MACROLIDES, ANTITUBERCULOSIS AND ANTI-DEPRSSSANTS....
X X X X Extracts X X X X
X X X X Extracts X X X X
.... AND MANUFACTRING SERVICES TO TRA-NSNATIONAL PHARMACEUTICAL COMPANIES 11,947.50 222.18 24 BARAKHAMBA ROAD, NEW DELHI-110001. Location: CHENNAI(TAMIL NADU) Appr No(Date): 130(28 February 2013) Item of Manufacture: PHARMACEUTICAL BUSINESS. 30 199 INVIDA INDIA PVT LTD., INVIDA PTE LTD., 15 October 2012 B-801, SAFAL SINGAPORE. PRAHALAD NAGAR ROAD, ANAND NAGAR, AHMEDABAD-380015. 100.00 0.00 0.00 100.00 Location AHMEDABAD(GUJARAT) Appr No(Date): 110(31 December 2012) Item of Manufacture: ENGAGED IN COMMERCIALIZING DIFFERENTIATED PHARMACEUTIVAL PRODUCTS OF SUPERIOR QUALITY. 31 228 CORDLIFE SCIENCES CORDLIFE 61.10 1.12 96.10 27 November 2012 (INDIA) PVT LTD., KOLKATA, SERVICES (S) PTE LTD., 43 ASHUTOSH SINGAPORE. CHOUDHURY AVENUE, SUNNY TOWERS, KOLKATA-700019. Location: CALCUTTA (WEST BENGAL) Appr No(Date): 2(31 March 2013) 32 244 30 November 2011 APTUIT LAURUS PVT LTD, 2ND FLOOR, SERENE CHAMBERS, ROAD #7,BANJARA HILLS, HYDERABAD-500034. Item of Manufacture: BUSINESS OF UMBILICAL CORD BLOOD STEM CELL BANKINGINCLUDING COLLECTION, PROCESSING, TESTING & CRYO PRESERVATION OF STEM CELL FOR THERAPEUTIC USES IN FUTURE. APTUIT 479....
X X X X Extracts X X X X
X X X X Extracts X X X X
.....57 9.75 3.40 (SINGAPORE) PVT LTD., SINGAPORE. 33 246 Location State Not Indicated (State Not Indicated) Appr No(Date): 1(29 February 2012) M/S SIDD LIFE 25 December SCIENCES PVT LTD. 2012 TAMIL NADU M/S SCIENCETEE PRIVATE LIMITED SINGAPORE Item of Manufacture: MFG OF CHEMICAL SUBSTANCES USED IN THE MANUFACTUREOF PHARMACEUTICALS. 618.35 11.24 97.43 SI. Registration Indian Company Name No No and Address and Date Foreign Collaborator Name and Address Foreign Equity in Rs million in US$million %age of Foreign Equity 34 163 C/O PVR RAJENDERA PRASAD PNP CONSULTING PVT. LTD. SUILTE #5, 1ST FLOOR RELIANCE CYBER VILLE VITTALRAO NAGAR MADHAPUR Location: CHENNAI(TAMIL NADU) Appr No(Date): 21(31 May 2013) Item of Manufacture: MANUFACTURING OF MEDICAL/SURGICAL EQUIPMENT & ORTH-OPEDIC APPLIANCES ETC. Total Financial Cases : 9 Total Foreign Equity in Rs million : 13,137.50 US$ million: 244.86 06 August 2012 ADOCOCK INGRAM HEALTHCARE PVT. LTD. BANGALORE, C/O AMARCHAND & MANGALDAS & SURESH A. SHROFF & CO. 5TH FLOOR, PENINSULA CHA- MBERS, PENINSULA CORPORA- TE PARK LOWERPAREL MUMBAI Location: BANGALORE (URBAN)(KARNATAKA) Country South....
X X X X Extracts X X X X
X X X X Extracts X X X X
.... Africa ADCOCK INGRAM HOLDINGS LTD SOUTH AFRICA THROUGH EITHER Appr No(Date): 105(30 November 2012) 4,800.00 87.63 100.00 Item of Manufacture: CURRENT ACTIVITY; MAINTAIN TRANSACTIONAL SUPPORT OFFICES WITH RESPECT TO THE HEALTHCARE AND PHARMA-CEUTICAL PROPOSED ACTIVITY BUSINESS OF MANUFACTUREMARKETING AND DISTRIBUTION OF HEALTHCARE AND PHARMACEUTICAL PRODUCTS Total Financial Cases : 1 Total Foreign Equity in Rs million 4,800.00 US$ million : 87.63 Country U.K. 3,085.10 69.33 20.00 35 41 ABBOTT CAPITAL INDIA ABBOTT CAPITAL 22 February 2010 LTD., UK, INDIA LTD., C/O LUTHRA & UK. LUTHRA, 103,ASHOKA ESTATE, BARAKHAMBA ROAD, NEW DELHI-110001. Location: GREATER MUMBAI (MUMBAI) (MAHARASHTRA) Appr No(Date): 37(30 April 2010) Item of Manufacture: TO ACT AS INVESTING COMPANY FOR BUSINESS OF PHARM-ACEUTICAL SECTOR INVOLVING WOMEN'S HEALTH, GASTROENTEROLOGY, MANTAL HEALTH & INFLUENZA VACCINES & OTHER PHARMACEUTICALS. 36 159 DASHTAG, UK C/O DASHTAG, UK VAKILS HOUSE 27 July 2012 SAGAR ASSOCIATES 18, SPROTT ROAD, BALLARD ESTATE, MUMBAI- 400001, 682.19 12.45 75.00 INDIA Location: GREATER MUMBAI (MUMBAI)(MAHARASHTRA) Appr No(Date): 99(30 Novem....
X X X X Extracts X X X X
X X X X Extracts X X X X
....ber 2012) Item of Manufacture: BUSINESS OF PHARMACEUTICALS SPECIALIZING IN DERMATOLOGY, ANTI-HISTAMINES, ANTIBIOTICS AND ONCOLOGY PRODUCTS Total Financial Cases : 2 Total Foreign Equity in Rs million : 3,767.29 : US$ million : 81.78 37 1 01 January 2013 SUNIJ PHARMA PVT LTD AHMEDABAD C/O RISHIT BAGADIYA Country U.S.A. MRS. FALGUNI N. KATWALA, USA (NRI/PIO) 4.65 0.08 76.32 SI. Registration Indian Company Name and Address No No and Date Foreign Collaborator Name and Address 38 2 908 ADITYA BUILDING OPP. SARDAR PATEL SEVA SAMAJ, NEAR GRUH FINANCE OFF CG ROAD, NAVRANGPURA, AHMEDABAD GUJRAT INDIA Foreign Equity in Rs million in US$million %age of Foreign Equity 05 December 2011 Location AHMEDABAD(GUJARAT) Appr No(Date): 17(31 May 2013) C. SAMPATH KUMAR, EDICT PHARMACEUTICALS PVT LTD., 1/58 PUDUPAKKAM MAIN ROAD KELAMBAKKAM- 603103, CHENNAI. PAR PHARMACEUTICAL INC., ONE RAM RIDGE ROAD, SPRING VALLEY, NEW YORK-10977. Location: CHENNAI(TAMIL NADU) Appr No(Date): 2(29 February 2012) Item of Manufacture: MANUFATURING AND MARKETING OF PHARMACEUTICAL FORMULATIONS AND FOOD PRODUCTS 15,979.31 325.00 100.00 Item of Manufacture: ....
X X X X Extracts X X X X
X X X X Extracts X X X X
....MANUFACTURE OF (I) TABLETS (II) CAPSULES FOR PHARMACEUTICAL FORMULATIONS. 39 47 THERDOSE PHARMA SCIDOSE LLC USA 15 March 2012 PVT. LTD PLOT NO. 118, 119 & 120, 0.00 0.00 SURVEY NO. 342ALEAP INDUSTRIAL ESTATE OPP. JNTU PRAGATI NAGAR KUKAT- PALLY, HYDERABAD- 500072 Location: HYDERABAD (TWIN CITIES)(ANDHRA PRADESH) Appr No(Date): 94(30 November 2012) PREMIER MEDICAL TRANSNATIONAL CORPORATION LTD. B- TECHNOLOGIES Item of Manufacture: MSNUFACTURING OF PHARMACEUTICAL PREPARATIONS 54,286.38 991.06 40 133 22 June 2012 2, PAREKH MAHAL, 80, VEER NARIMAN ROAD CHURCHGATE, MUMBAI-400020 INC. NEW JERSY 74.00 99.99 Location: GREATER MUMBAI (MUMBAI) (MAHARASHTRA) Appr No(Date): 102(30 November 2012) Item of Manufacture: CURRENT ACTIVITY- ENGAGED IN THE BUSINESS OF DEVE-LOPING STRATEGIC ALLIANCE FOR SEVERAL DIAGNOSTIC - PRODUCTS IN INDIA AND DEVELOPS, MANUFACTURES A WIDE RANGE OF RAPID DIAGNOSTIC PRODUCTS FOR EXPORT 41 240 AKORN INC., C/O 28 November KHAITAN & CO., AKORN INC., USA. 2011 801, ASHOKA ESTATE, NEW DELHI-110001. Location State Not Indicated (State Not Indicated) 42 254 Appr No(Date): 2(29 February 2012) PHARMACEUTICAL LEVOM....
X X X X Extracts X X X X
X X X X Extracts X X X X
....ED INC., 19 December 2011 INGREDIENTS & USA. FORMULATIONS INDIA PVT LTD, NO.15, BLOCK- 2,842.05 57.80 Item of Manufacture: ENGAGED IN PHARMACEUTICAL SECTOR. 0.00 100.00 0.00 100.00 SI. Registration Indian Company Name No No and Address and Date Foreign Collaborator Name and Address Foreign Equity in Rs million in US$million %age of Foreign Equity BLESSING GARDENS, BYRATHI, DODDA GUBBI POST, BANGALORE-560077. Location State Not Indicated (State Not Indicated) Appr No(Date): 9(29 February 2012) Item of Manufacture: MANUFACTURING, MARKETING & EXPORTING OF PHARMACEUTICAL PRODUCTS & DIETARY SUPPLEMENTS. Total Financial Cases : 6 Total Foreign Equity in Rs million : 73,112.38 : US$ million : 1,373.95 AMAR REMEDIES LTD., FIIS. Country FII's 1,700.00 32.27 5.05 43 208 20 October 2011 UNIT NO.01, WING B-I, INNOVA, MARATHON NEXTGEN, OFF GANPATRAO KADAM MARG, LOWER PAREL (W), MUMBAI-400013. Location State Not Indicated (State Not Indicated) Appr No(Date): 106(31 December 2011) Total Financial Cases Item of Manufacture: BUSINESS OF MFG & MARKETING PERSONAL CARE AND OTC PRODUCTS. 1 Total Foreign Equity in Rs million 1,700.00 US$ milli....
X X X X Extracts X X X X
X X X X Extracts X X X X
....on : 32.27<BR> News - Press release - PIB....